FOR THE FIRST TIME: The patient was given a cancer vaccine.

The first personalized local onco-vaccine was administered to a patient in Russia on April 1. The press service of the Ministry of Health of the Russian Federation reported this. At the National Medical Research Center of Radiology of the Russian Ministry of Health, for the first time in clinical practice, a personalized "Neooncovac" mRNA anti-tumor vaccine was applied to a patient with skin melanoma. The first patient was a 60-year-old man from Kursk region diagnosed with skin melanoma. The patient is currently undergoing immunotherapy. Despite continuing treatment, the risk of disease progression remains high and the standard medical options are quite limited. In such a situation, the application of a personalized mRNA vaccine is considered a means of disease control.// Musavat.com